Works by Akita, Hirofumi

Results: 110
    1
    2
    3
    4
    5

    The POU5F1 gene expression in colorectal cancer: a novel prognostic marker.

    Published in:
    Surgery Today, 2018, v. 48, n. 7, p. 709, doi. 10.1007/s00595-018-1644-9
    By:
    • Miyoshi, Norikatsu;
    • Fujino, Shiki;
    • Ohue, Masayuki;
    • Yasui, Masayoshi;
    • Takahashi, Yusuke;
    • Sugimura, Keijiro;
    • Tomokuni, Akira;
    • Akita, Hirofumi;
    • Kobayashi, Shogo;
    • Takahashi, Hidenori;
    • Omori, Takeshi;
    • Miyata, Hiroshi;
    • Yano, Masahiko
    Publication type:
    Article
    6
    7

    Clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids obtained pre- and post-lymphadenectomy from gastric cancer patients.

    Published in:
    Surgery Today, 2016, v. 46, n. 6, p. 654, doi. 10.1007/s00595-015-1235-y
    By:
    • Sugimura, Keijiro;
    • Fujiwara, Yoshiyuki;
    • Omori, Takeshi;
    • Motoori, Masaaki;
    • Miyoshi, Norikatsu;
    • Akita, Hirofumi;
    • Gotoh, Kunihito;
    • Kobayashi, Shogo;
    • Takahashi, Hidenori;
    • Noura, Shingo;
    • Ohue, Masayuki;
    • Yamamoto, Takashi;
    • Sakon, Masato;
    • Yano, Masahiko
    Publication type:
    Article
    8
    9
    10

    Prognostic Value of a Novel Index Combining the Prognostic Nutritional Index and D-Dimer Levels for Gastric Cancer after Gastrectomy.

    Published in:
    Oncology, 2025, v. 103, n. 1, p. 1, doi. 10.1159/000533150
    By:
    • Yamamoto, Masaaki;
    • Omori, Takeshi;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Mukai, Yosuke;
    • Sugase, Takahito;
    • Takeoka, Tomohira;
    • Kanemura, Takashi;
    • Mikamori, Manabu;
    • Hasegawa, Shinichiro;
    • Akita, Hirofumi;
    • Haraguchi, Naotsugu;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Matsuda, Chu;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi;
    • Ohue, Masayuki
    Publication type:
    Article
    11

    Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 484, doi. 10.1159/000535186
    By:
    • Sugase, Takahito;
    • Kanemura, Takashi;
    • Takeoka, Tomohira;
    • Matsuura, Norihiro;
    • Masuike, Yasunori;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Omori, Takeshi;
    • Kitakaze, Masatoshi;
    • Kubo, Masahiko;
    • Mukai, Yosuke;
    • Sueda, Toshinori;
    • Hasegawa, Shinichiro;
    • Akita, Hirofumi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    12

    Clinicopathological Characteristics and Survival Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Who Were Intraoperatively Diagnosed Non-Curative.

    Published in:
    Oncology, 2024, v. 102, n. 5, p. 339, doi. 10.1159/000533772
    By:
    • Sugase, Takahito;
    • Kanemura, Takashi;
    • Takeoka, Tomohira;
    • Sugimura, Keijiro;
    • Yamamoto, Masaaki;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Omori, Takeshi;
    • Mukai, Yosuke;
    • Mikamori, Manabu;
    • Hasegawa, Shinichiro;
    • Haraguchi, Naotsugu;
    • Akita, Hirofumi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Matsuda, Chu;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    13

    Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer.

    Published in:
    Oncology, 2022, v. 100, n. 12, p. 655, doi. 10.1159/000527196
    By:
    • Sugase, Takahito;
    • Sugimura, Keijiro;
    • Kanemura, Takashi;
    • Takeoka, Tomohira;
    • Yamamoto, Masaaki;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Omori, Takeshi;
    • Fujii, Yoshiaki;
    • Mukai, Yosuke;
    • Mikamori, Manabu;
    • Hasegawa, Shinichiro;
    • Haraguchi, Naotsugu;
    • Akita, Hirofumi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Matsuda, Chu;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    14
    15

    ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4702, doi. 10.1245/s10434-024-15244-6
    By:
    • Yamada, Daisaku;
    • Kobayashi, Shogo;
    • Takahashi, Hidenori;
    • Iwagami, Yoshifumi;
    • Akita, Hirofumi;
    • Asukai, Kei;
    • Shimizu, Junzo;
    • Yamada, Terumasa;
    • Tanemura, Masahiro;
    • Yokoyama, Shigekazu;
    • Tsujie, Masanori;
    • Asaoka, Tadafumi;
    • Takeda, Yutaka;
    • Morimoto, Osakuni;
    • Tomokuni, Akira;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    16

    Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4621, doi. 10.1245/s10434-024-15199-8
    By:
    • Yamada, Daisaku;
    • Kobayashi, Shogo;
    • Takahashi, Hidenori;
    • Iwagami, Yoshifumi;
    • Akita, Hirofumi;
    • Asukai, Kei;
    • Shimizu, Junzo;
    • Yamada, Terumasa;
    • Tanemura, Masahiro;
    • Yokoyama, Shigekazu;
    • Tsujie, Masanori;
    • Asaoka, Tadafumi;
    • Takeda, Yutaka;
    • Morimoto, Osakuni;
    • Tomokuni, Akira;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    17

    Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 2, p. 818, doi. 10.1245/s10434-023-14306-5
    By:
    • Kanemura, Takashi;
    • Takeoka, Tomohira;
    • Sugase, Takahito;
    • Urakawa, Shinya;
    • Masuike, Yasunori;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Kitakaze, Masatoshi;
    • Kubo, Masahiko;
    • Mukai, Yousuke;
    • Sueda, Toshinori;
    • Hasegawa, Shinichiro;
    • Akita, Hirofumi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Yasui, Masayoshi;
    • Omori, Takeshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    18
    19
    20
    21

    Endogenous CXCL9 affects prognosis by regulating tumor‐infiltrating natural killer cells in intrahepatic cholangiocarcinoma.

    Published in:
    Cancer Science, 2020, v. 111, n. 2, p. 323, doi. 10.1111/cas.14267
    By:
    • Fukuda, Yasunari;
    • Asaoka, Tadafumi;
    • Eguchi, Hidetoshi;
    • Yokota, Yuki;
    • Kubo, Masahiko;
    • Kinoshita, Mitsuru;
    • Urakawa, Shinya;
    • Iwagami, Yoshifumi;
    • Tomimaru, Yoshito;
    • Akita, Hirofumi;
    • Noda, Takehiro;
    • Gotoh, Kunihito;
    • Kobayashi, Shogo;
    • Hirata, Michinari;
    • Wada, Hisashi;
    • Mori, Masaki;
    • Doki, Yuichiro
    Publication type:
    Article
    22

    Plasma mi R-21 is a novel diagnostic biomarker for biliary tract cancer.

    Published in:
    Cancer Science, 2013, v. 104, n. 12, p. 1626, doi. 10.1111/cas.12300
    By:
    • Kishimoto, Tomoya;
    • Eguchi, Hidetoshi;
    • Nagano, Hiroaki;
    • Kobayashi, Shogo;
    • Akita, Hirofumi;
    • Hama, Naoki;
    • Wada, Hiroshi;
    • Kawamoto, Koichi;
    • Tomokuni, Akira;
    • Tomimaru, Yoshito;
    • Umeshita, Koji;
    • Doki, Yuichiro;
    • Mori, Masaki
    Publication type:
    Article
    23

    Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 4, p. 303, doi. 10.1007/s00280-023-04531-w
    By:
    • Nishi, Hidemi;
    • Gotoh, Kunihito;
    • Tomimaru, Yoshito;
    • Kobayashi, Shogo;
    • Sasaki, Kazuki;
    • Iwagami, Yoshifumi;
    • Yamada, Daisaku;
    • Akita, Hirofumi;
    • Asaoka, Tadafumi;
    • Noda, Takehiro;
    • Takahashi, Hidenori;
    • Tanemura, Masahiro;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    24
    25

    Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes.

    Published in:
    Cells (2073-4409), 2020, v. 9, n. 7, p. 1645, doi. 10.3390/cells9071645
    By:
    • Takeda, Yu;
    • Kobayashi, Shogo;
    • Kitakaze, Masatoshi;
    • Yamada, Daisaku;
    • Akita, Hirofumi;
    • Asai, Ayumu;
    • Konno, Masamitsu;
    • Arai, Takahiro;
    • Kitagawa, Toru;
    • Ofusa, Ken;
    • Yabumoto, Masami;
    • Hirotsu, Takaaki;
    • Vecchione, Andrea;
    • Taniguchi, Masateru;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi;
    • Ishii, Hideshi
    Publication type:
    Article
    26

    Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015).

    Published in:
    2021
    By:
    • Yamada, Daisaku;
    • Kobayashi, Shogo;
    • Takahashi, Hidenori;
    • Akita, Hirofumi;
    • Yamada, Terumasa;
    • Asaoka, Tadafumi;
    • Shimizu, Junzo;
    • Takeda, Yutaka;
    • Yokoyama, Shigekazu;
    • Tsujie, Masanori;
    • Tomokuni, Akira;
    • Tanemura, Masahiro;
    • Morimoto, Osakuni;
    • Murakami, Masahiro;
    • Kim, Yongkook;
    • Nakahira, Shin;
    • Hama, Naoki;
    • Sugimoto, Keishi;
    • Hashimoto, Kazuhiko;
    • Doki, Yuichiro
    Publication type:
    journal article
    27

    DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10512-2
    By:
    • Hasegawa, Shinichiro;
    • Takahashi, Hidenori;
    • Akita, Hirofumi;
    • Mukai, Yosuke;
    • Mikamori, Manabu;
    • Asukai, Kei;
    • Yamada, Daisaku;
    • Wada, Hiroshi;
    • Fujii, Yoshiaki;
    • Sugase, Takahito;
    • Yamamoto, Masaaki;
    • Takeoka, Tomohira;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Kanemura, Takashi;
    • Haraguchi, Naotsugu;
    • Nishimura, Junichi;
    • Matsuda, Chu;
    • Yasui, Masayoshi;
    • Omori, Takeshi
    Publication type:
    Article
    28
    29

    CD13 is a therapeutic target in human liver cancer stem cells.

    Published in:
    2010
    By:
    • Haraguchi, Naotsugu;
    • Ishii, Hideshi;
    • Mimori, Koshi;
    • Tanaka, Fumiaki;
    • Ohkuma, Masahisa;
    • Ho Min Kim;
    • Akita, Hirofumi;
    • Takiuchi, Daisuke;
    • Hatano, Hisanori;
    • Nagano, Hiroaki;
    • Barnard, Graham F.;
    • Doki, Yuichiro;
    • Mori, Masaki;
    • Kim, Ho Min
    Publication type:
    journal article
    30

    Prognostic impact of aberrant right hepatic artery involvement in patients with pancreatic cancer: A multicenter retrospective cohort study.

    Published in:
    Journal of Surgical Oncology, 2024, v. 130, n. 3, p. 504, doi. 10.1002/jso.27792
    By:
    • Ueda, Hiroki;
    • Takahashi, Hidenori;
    • Akita, Hirofumi;
    • Tomimaru, Yoshito;
    • Kobayashi, Shogo;
    • Kubo, Masahiko;
    • Mukai, Yousuke;
    • Toshiyama, Reishi;
    • Sasaki, Kazuki;
    • Hasegawa, Shinichiro;
    • Iwagami, Yoshifumi;
    • Sakai, Kenji;
    • Yamada, Daisaku;
    • Noda, Takehiro;
    • Asaoka, Tadafumi;
    • Wada, Hiroshi;
    • Gotoh, Kunihito;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Enterococcus spp. have higher fitness for survival, in a pH‐dependent manner, in pancreatic juice among duodenal bacterial flora.

    Published in:
    JGH Open, 2022, v. 6, n. 1, p. 85, doi. 10.1002/jgh3.12703
    By:
    • Itoyama, Saki;
    • Noda, Emika;
    • Takamatsu, Shinji;
    • Kondo, Jumpei;
    • Kawaguchi, Rui;
    • Shimosaka, Munefumi;
    • Fukuoka, Tomoya;
    • Motooka, Daisuke;
    • Nakamura, Shota;
    • Tanemura, Masahiro;
    • Mitsufuji, Suguru;
    • Iwagami, Yoshifumi;
    • Akita, Hirofumi;
    • Tobe, Toru;
    • Kamada, Yoshihiro;
    • Eguchi, Hidetoshi;
    • Miyoshi, Eiji
    Publication type:
    Article
    37
    38
    39

    Optimal treatment strategy for patients with pancreatic cancer having positive peritoneal cytology: A nationwide multicenter retrospective cohort study supervised by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2025, v. 32, n. 1, p. 69, doi. 10.1002/jhbp.12074
    By:
    • Ariake, Kyohei;
    • Mizuma, Masamichi;
    • Unno, Michiaki;
    • Satoi, Sohei;
    • Yamamoto, Naoto;
    • Hayashi, Masamichi;
    • Kawai, Manabu;
    • Akita, Hirofumi;
    • Toyoda, Eiji;
    • Fujii, Tsutomu;
    • Sasaki, Masaru;
    • Hakamada, Kenichi;
    • Watanabe, Jota;
    • Hatano, Etsuro;
    • Hidaka, Masaaki;
    • Hirano, Satoshi;
    • Kurahara, Hiroshi;
    • Matsumoto, Ippei;
    • Honda, Goro;
    • Ogura, Toshiro
    Publication type:
    Article
    40

    The malignant potential of pancreatic intraductal papillary mucinous neoplasm is reflected in expression levels of fucosylated glycans in α<sub>1</sub>‐acid glycoprotein.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 4, p. 503, doi. 10.1002/jhbp.1208
    By:
    • Kubo, Norio;
    • Yazawa, Shin;
    • Yokobori, Takehiko;
    • Sano, Rie;
    • Eguchi, Hidetoshi;
    • Kobayashi, Shogo;
    • Akita, Hirofumi;
    • Mitsufuji, Suguru;
    • Yamashita, Yo‐ichi;
    • Nakao, Yosuke;
    • Fujii, Tsutomu;
    • Okumura, Tomoyuki;
    • Shibuya, Kazuto;
    • Hoshino, Yui;
    • Yamada, Suguru;
    • Hayashi, Masamichi;
    • Shimokawa, Mototsugu;
    • Shirabe, Ken
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer.

    Published in:
    World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02747-3
    By:
    • Takayama, Hirotoshi;
    • Kobayashi, Shogo;
    • Gotoh, Kunihito;
    • Sasaki, Kazuki;
    • Iwagami, Yoshifumi;
    • Yamada, Daisaku;
    • Tomimaru, Yoshito;
    • Akita, Hirofumi;
    • Asaoka, Tadafumi;
    • Noda, Takehiro;
    • Wada, Hiroshi;
    • Takahashi, Hidenori;
    • Tanemura, Masahiro;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    47
    48
    49

    SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor–stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10935, doi. 10.1007/s00432-023-04835-7
    By:
    • Takayama, Hirotoshi;
    • Kobayashi, Shogo;
    • Gotoh, Kunihito;
    • Sasaki, Kazuki;
    • Iwagami, Yoshifumi;
    • Yamada, Daisaku;
    • Tomimaru, Yoshito;
    • Akita, Hirofumi;
    • Asaoka, Tadafumi;
    • Noda, Takehiro;
    • Wada, Hiroshi;
    • Takahashi, Hidenori;
    • Tanemura, Masahiro;
    • Doki, Yuichiro;
    • Eguchi, Hidetoshi
    Publication type:
    Article
    50